Risk Assessment and Patient Management in MDS: Now and into the Future

Risk Assessment and Patient Management in MDS: Now and into the Future
Risk Assessment and Patient Management in MDS: Now and into the Future
CNE
Steven D. Gore, MD; Rami S. Komrokji, MD; Shannon R. McCurdy, MD; and Azra Raza, MD
Release Date: April 15, 2019
Expiration Date: April 15, 2020

This activity will address several practice-related issues regarding the management of patients with myelodysplastic syndromes. Nurses who provide direct patient care may encounter many different hematologic malignancies throughout their day. Consequently, they may face the challenge of remaining current on treatment and monitoring approaches for myelodysplastic syndromes. In this text-based activity, four expert faulty provide the background and insights needed to properly manage this patient population. Topics include accurate risk assessment, iron chelation, managing anemia, and understanding future directions in therapy.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Onconova Therapeutics, Inc.
Begin, Earn CreditView Only, No CreditGet Certificate